HMG 75IU

This guide helps laboratory teams evaluate HMG identity, COA records, analytical testing, lot traceability, and published research. HMG is associated with menotropin terminology, follicle-stimulating hormone activity, and luteinizing hormone activity. The listed material is intended for research use only, not consumer, clinical, diagnostic, or personal use.

• HMG is commonly aligned with menotropins, a gonadotrophin preparation described by NIH resources as containing follicle-stimulating hormone and luteinizing hormone activity derived from postmenopausal urine sources [1] [2].
• The term HMG may appear alongside human menopausal gonadotropin, human menopausal gonadotrophin, menotrophin, menotropin, and menotropins in research and database contexts [1] [3].
• Researchers evaluate HMG documentation for identity, source context, analytical testing, purity reporting, COA consistency, lot number alignment, and RUO labeling.
• Published literature provides scientific background but does not establish effects of the listed material.
• Official and academic sources describe gonadotropins as glycoprotein hormones with alpha and beta subunits, receptor-specific signaling, and complex molecular characterization needs [4] [5].
• COA review should connect product information, batch-specific documentation, method notes, chromatographic data, and supplier documentation.
• Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.

Fast Answer: What Should Researchers Check Before They Buy HMG for Research?

Researchers looking to buy HMG for research should first review RUO labeling, compound identity, CAS or database identifiers, batch-specific COA documentation, analytical testing methods, lot traceability, supplier documentation, and storage records. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption. Literature context should remain separate from product claims.

What Documentation Should Come Before Researchers Buy HMG for Research?

Before researchers buy HMG for research, the documentation package should answer a simple question: does the label, COA, and product information tell the same technical story?

For HMG, that story may include human menopausal gonadotropin terminology, menotropin or menotrophin naming, FSH and LH activity references, and analytical data that supports identity and purity review. PubChem describes menotropins as containing follicle stimulating hormone and luteinizing hormone purified from postmenopausal urine [1]. NCBI MeSH similarly identifies menotropins as urine extracts from menopausal women containing pituitary gonadotropins, follicle-stimulating hormone, and luteinizing hormone [2].

A product listing may also include catalog activity notation such as HMG 75 IU or 75iu.

Why RUO Labeling Matters for HMG Research Materials?

RUO labeling helps separate laboratory research materials from consumer, diagnostic, therapeutic, clinical, or veterinary positioning. FDA guidance for RUO-labeled IVD products explains that RUO labeling is tied to research-phase products and should not be used to support clinical diagnostic positioning [6].

Some HMG database records and studies include clinical terminology. That terminology does not establish suitability of this RUO material for clinical use.

RUO Context for HMG Laboratory Research

HMG is a gonadotrophin research topic with overlap across peptide, protein, hormone, and glycoprotein hormone terminology. NIH LiverTox describes human gonadotropins such as follicle stimulating hormone, luteinizing hormone, and chorionic gonadotropin as heterodimeric peptide-hormone proteins made of two peptide chains, with a shared alpha chain and hormone-specific beta chains [4]. That makes molecular identity review more complex than a single small synthetic peptide.

What Research Use Labeling Should Make Clear?

Research use labeling should make the intended context unmistakable.

The label should also connect to documents that a research team can archive. That includes product information, lot number, batch-specific certificate of analysis, analytical testing method, and storage documentation. If the label and COA do not match, procurement teams should pause the review.

Why Laboratory Research Use Stays Separate From Product Claims?

Laboratory research use stays separate from product claims because published literature and product documentation serve different roles. Literature may describe a compound class, receptor system, analytical method, or model-specific finding. Product documentation should describe the material being supplied, the lot being reviewed, and the testing record attached to that lot.

Some HMG literature concerns clinical settings. Those findings do not establish an approved or appropriate use for the research-use-only material supplied.

How Controlled Laboratory Records Support Research Materials

Controlled laboratory records give procurement teams a way to track what was reviewed, when it was reviewed, and which batch the review covered. Useful records include the product information page, lot number, COA, test method, chromatographic file when available, storage note, and internal receiving log.

This is especially relevant for research materials such as HMG because the broader menotropin category can involve multiple glycoprotein components and variable purity across preparations. NCBI MeSH notes that the FSH:LH ratio and degree of purity can vary across menotropin preparations [2].

What Is HMG in Research Literature?

HMG stands for human menopausal gonadotropin or human menopausal gonadotrophin in many research and database contexts. It is commonly associated with menotropin or menotropins, which PubChem describes as containing FSH and LH purified from postmenopausal urine [1].

HMG is a gonadotrophin and glycoprotein hormone material, not a simple single-chain peptide with one sequence and molecular weight.

Compound Identity and CAS Documentation

Begin identity review with the compound name, synonyms, database identifiers, and CAS information where available. FDA’s Global Substance Registration System lists menotropins with synonyms including human menopausal gonadotrophin [3] . NCBI MeSH lists menotropins as a controlled vocabulary term introduced in 1973 [2] .

For procurement review, CAS information should not stand alone. CAS, synonym, and product-name alignment should be compared against COA identity data and supplier documentation.

Human Menopausal Gonadotropin and Menotrophin Naming

Human menopausal gonadotropin, human menopausal gonadotrophin, menotrophin, menotropin, and menotropins may appear across scientific and regulatory sources. This naming variation can matter during supplier evaluation because different records may use different naming conventions for the same broader HMG category.

Why Glycoprotein Hormone Classification Matters?

Glycoprotein hormone classification matters because gonadotropins are not simple small molecules. Academic reviews describe gonadotropins as glycoprotein hormones with common alpha subunit architecture and hormone-specific beta subunits [5] [7]. This structure supports the need for careful identity documentation, source review, and analytical method context.

It also affects how researchers read literature. A paper discussing FSH, LH, hCG, or receptor signaling may provide useful background, but it does not automatically describe a specific HMG research material.

Reviewing HMG Documentation From Pure Lab Peptides

Compare identity records, the COA, analytical testing, lot traceability, RUO labeling, and supplier documentation.

How Does Product Information Support Technical Review?

Use the listing to identify the compound name, synonyms, research classification, catalog activity notation, and available COA. Compare those fields with the batch-specific records.

Product information should not replace batch-specific documents. It is the starting point, not the whole review.

What Should a Research Material Listing Clarify?

Check the compound name, RUO status, lot-level documentation, and analytical testing basis. Catalog specifications describe the listed material; they are not experimental instructions.

For HMG, a listing might reference 75 IU as an activity designation if that is how the catalog identifies the material. Official menotropin label descriptions also use IU activity terminology for FSH and LH activity per vial [8].

Why Vial Details Stay in Catalog Context?

Vial details are catalog information. They should help identify the product listing, match the COA, and support inventory records.

Scientific Background for Gonadotrophin Research

Gonadotrophin research connects HMG with FSH, LH, hCG, glycoprotein hormone structure, and receptor signaling. NIH LiverTox describes FSH and LH as pituitary gonadotropins and hCG as a chorionic gonadotropin, all within the human gonadotropin group [4].

This background explains material classification, not an intended application for the supplied product.

Where Follicle-Stimulating Hormone Context Fits

Follicle-stimulating hormone context fits into HMG identity because menotropins are associated with FSH activity. The FSH receptor gene, FSHR, encodes a G protein-coupled receptor for follicle stimulating hormone according to NCBI Gene [9]. UniProt also identifies human FSHR as the follicle-stimulating hormone receptor [10].

How Luteinizing Hormone References Support Identity Review

Luteinizing hormone references support identity review because HMG materials are commonly described in relation to FSH and LH activity. NCBI Gene identifies LHCGR as the luteinizing hormone/choriogonadotropin receptor and describes it as a G protein-coupled receptor whose activity is mediated through G proteins that activate adenylate cyclase [11]. UniProt identifies LHCGR as a receptor for lutropin-choriogonadotropic hormone [12].

These receptor records provide background for literature interpretation, not evidence of effects of the supplied material.

Where Chorionic Gonadotropin References Belong

Chorionic gonadotropin references belong in the literature context because some HMG and highly purified human menopausal gonadotrophin preparations have been studied for hCG abundance and glycan profiles. A 2024 analytical investigation used liquid chromatography–tandem mass spectrometry to examine FSH, LH, hCG, glycopeptides, oxidation, and impurity patterns in highly purified HMG preparations [13].

This is useful for research interpretation because it shows why analytical documentation can matter for complex glycoprotein hormone materials. It should not be converted into a claim about any specific RUO lot unless that lot has matching batch-specific documentation.

Molecular and Receptor Context for HMG

HMG research sits at the intersection of molecular identity, glycoprotein hormone biology, and receptor-pathway literature. Gonadotropin reviews describe FSH, LH, and hCG as related glycoprotein hormones with receptor-specific signaling features [5] [14].

That molecular context is relevant for documentation. It helps explain why HMG review should look beyond a single name field and include source, purity, method, and lot-specific records.

How Does Receptor Literature Frame HMG Research?

Receptor literature frames HMG research through FSHR and LHCGR context. FSHR is the receptor for FSH, while LHCGR is the receptor for luteinizing hormone and chorionic gonadotropin [9] [11]. Reviews of gonadotropin receptors describe these systems as G protein-coupled receptor pathways with complex regulation and signaling outputs [15].

What Can Follicular Signaling Models Clarify?

Follicular signaling models can clarify how FSH and LH literature is organized. They may discuss receptor engagement, second messenger pathways, steroidogenesis models, or cell signaling systems. Reviews of gonadotropin signaling discuss cAMP/PKA, ERK, AKT, and beta-arrestin-related pathway concepts in research settings [5] [14].

Those models are evidence context.

Why Pathway Context Should Not Become Product Claims?

A pathway result reported in a study is not evidence of an effect of a supplied research material. Evaluate the identity, batch, method, COA, lot number, and RUO labeling separately.

Published Literature Context for HMG Research

Published literature on HMG and related gonadotropins includes database descriptions, compositional studies, glycoprotein hormone reviews, receptor papers, and analytical characterization work. A compositional analysis of a urinary-derived HMG preparation examined composition and impurities, highlighting the value of analytical review for complex gonadotrophin materials [16]. The 2024 HP-hMG analysis further shows how LC-MS/MS can be used to examine glycopeptide mapping and impurity profiles [13].

Distinguish each source’s role in the evidence summary below.

What Published Literature Can and Cannot Show?

Published literature can show how researchers describe HMG, menotropins, gonadotropins, receptor systems, glycoprotein hormone structure, and analytical characterization. It can also show how study authors evaluate impurities, glycosylation, receptor signaling, or method performance.

Published literature cannot replace a batch-specific COA. It also cannot confirm the identity, purity, or documentation status of a specific HMG research material unless the material and lot under review are directly tied to the evidence.

How Does In Vitro Research Fit the Evidence Map?

In vitro research fits the evidence map as model-specific scientific context. For example, LH and hCG receptor literature discusses ligand-receptor signaling and pathway differences in in vitro models [14]. Gonadotropin signaling reviews also discuss biased signaling and receptor pathway complexity [5].

Where Source Quality Review Matters Most

For HMG, researchers should prefer official databases, PubMed-indexed literature, analytical chemistry sources, and standards organizations over vendor summaries or unsourced marketing content.

A strong source-quality filter is:

• Official database for identity.
• Peer-reviewed paper for pathway or analytical claims.
• Standards or guidance source for documentation principles.
• Batch-specific COA for lot-level review.
• Supplier documentation for product listing consistency.

Some published HMG-related studies concern human settings. Those findings are outside the scope of RUO product use and do not establish suitability of research-use-only materials for human use.

How Do Study Findings Differ From Product Claims?

Study findings differ from product claims because studies evaluate defined models, materials, methods, and endpoints. Product claims imply something about the supplied material.

In HMG research, a paper on gonadotropin signaling can explain receptor pathways. A COA can document analytical results for a batch.

For procurement, check identity, naming, CAS records, COA fields, method details, purity results, lot traceability, and storage records.

COA Documentation for HMG Research Materials

COA documentation is central to HMG research procurement. A certificate of analysis should be batch-specific and should connect the compound name, lot number, testing method, purity data, identity data, and document date.

NIST reference material guidance explains that certified properties are backed by a certificate of analysis and that traceability connects values and properties to a higher-order reference system when applicable [17]. Although an HMG supplier COA is not the same as a NIST certificate, the documentation principle is useful: values should be stated clearly, and the record should identify what was measured.

Why Certificate of Analysis Review Matters?

Certificate of analysis review matters because a product listing is general, while a COA should be batch-specific. The COA gives the procurement team a document to compare against the label and product information.

For HMG, the COA should support research material review by showing which analytical method was used and which lot the data describes. It should not be treated as a substitute for all quality review.

What Batch-Specific Documentation Should Include?

Batch-specific documentation should include the compound name, lot number, COA date, analytical method, purity or identity result where available, and storage documentation. It may also include lab source, third-party testing status, chromatogram record, or mass data.

For complex glycoprotein hormone research materials, method context matters. Studies of highly purified HMG preparations have used LC-MS/MS and glycopeptide mapping to examine molecular composition and impurity patterns [13].

How COA Dates Support Traceability Review

COA dates support traceability by showing when the batch record was generated or released. They also help procurement teams match records to receiving logs and supplier communications.

A COA without a date, lot number, or method field is weaker than a batch-specific record with aligned documentation.

Purity and Identity Testing Considerations

Purity and identity testing answer related but different questions. Purity review asks what proportion of detected signal or measured material aligns with the target under the stated method. Identity review asks whether the material corresponds to the expected compound or component profile.

ICH Q2(R2) identifies analytical procedure validation concepts for assay, purity, impurity, identity, and other qualitative or quantitative measurements [18]. For research procurement, this supports the idea that method purpose should be clear.

How HPLC Supports Purity Review

HPLC supports purity review by separating sample components and producing chromatographic data that can show relative peak patterns under specified conditions. A peptide analysis review describes HPLC as a major tool for peptide analysis and purification across modes such as reversed-phase, ion-exchange, and size-exclusion chromatography [19].

For HMG, HPLC data should be interpreted with method notes. A chromatogram is more useful when it is tied to a lot number, method, detector, and COA date.

How LC-MS Supports Identity Verification

LC-MS supports identity verification by combining chromatographic separation with mass spectrometry data. LC-MS methods are widely used to analyze peptides and proteins on chromatographic timescales, and LC-MS/MS can support peptide or glycopeptide mapping [20] [21].

For HMG materials, LC-MS or LC-MS/MS documentation may be especially relevant because the research category can involve glycoprotein hormone components rather than a single short peptide.

Why Chromatography Data Needs Method Context?

Chromatography data needs method context because retention time, peak shape, detector type, and sample conditions affect interpretation. ICH Q2(R2) lists separation techniques such as HPLC in the context of analytical validation examples [18].

A chromatogram without method context is only partial evidence. A stronger documentation package links the chromatogram to a COA, lot number, and method summary.

Analytical Verification Workflow for Research Procurement

Use the following workflow to verify records before procurement:

1. Verify the compound name, synonym set, and lot number across the product listing, label, and COA.
2. Review the batch-specific certificate of analysis.
3. Check whether the purity method is listed and whether HPLC, chromatography, or another suitable method is identified.
4. Confirm whether identity testing is supported by LC-MS, LC-MS/MS, mass spectrometry, or another stated analytical method.
5. Review chromatogram or mass data when available.
6. Check the COA date, lab source, and third-party documentation status.
7. Archive storage and handling requirements in a controlled laboratory record.
8. Record any mismatch between product information, COA data, and supplier documentation.

What Mass Spectrometry Can Confirm?

Mass spectrometry can support molecular identity review by measuring mass-related signals and, in tandem methods, fragmentation patterns. LC-MS/MS peptide mapping has been used in protein characterization workflows, including sequence-dependent digestion maps and peptide identification [21]. A 2023 study also evaluated LC-MS identification challenges for short homologous peptides, showing that identity assignment can require careful method design [22].

For HMG, mass spectrometry should be interpreted within the method and sample context. It is one part of the documentation package.

How Reference Standards Support Method Review

Reference standards support method review by giving laboratories a defined comparison point when available. USP authors have described reference standards as important tools for peptide quality attributes such as identity and purity in regulated peptide contexts [23]. NIST also explains that reference materials can support accurate measurements, method validation, and quality assurance [17].

For RUO procurement, the practical takeaway is not to assume. Review whether the documentation explains the method basis and any reference material used.

Supplier Documentation, Labeling, and Storage Records

Supplier documentation should connect the product page, label, COA, and storage record. ISO describes ISO/IEC 17025 as a standard that helps testing and calibration laboratories demonstrate competence and generate valid results [24]. NIST’s own measurement-services quality system references ISO/IEC 17025 as part of its measurement-service framework [25].

Check whether supplier documentation is sufficiently clear and complete to evaluate the material; resolve gaps with the supplier.

How Do Lot Numbers Connect Labels and COAs?

Lot numbers connect labels and COAs by tying a physical catalog item to a batch-specific record. If the lot number on the label does not match the COA, the documentation chain is incomplete.

For HMG research materials, this match is especially important because a product name alone does not confirm lot-level purity, identity, or analytical data.

Why Storage Documentation Supports Research Material Review?

Storage documentation supports research material review by showing how the supplier expects the laboratory to maintain the material record. Storage records may include temperature language, light exposure notes, document dates, or receiving-log fields.

Record supplier storage information and apply the laboratory’s controlled handling and recordkeeping policies.

Research Procurement Checklist Before Researchers Buy HMG for Research

Use this checklist before researchers buy HMG for research:

• Verify that HMG is labeled for research-use-only purposes.
• Confirm the product name, synonyms, and CAS or database references where available.
• Review the batch-specific certificate of analysis.
• Check that the lot number matches across product documentation.
• Compare purity and identity methods across COA and supplier documentation.
• Assess whether analytical testing includes HPLC, LC-MS, mass spectrometry, chromatography, or another stated method.
• Document storage and handling requirements in a controlled laboratory record.
• Evaluate whether the product page avoids consumer, clinical, and product-claim framing.
• Archive all procurement records before the material enters the research inventory.

What Supplier Documentation Should Be Compared?

Compare the product listing, label, COA, test report, lot number, storage note, supplier contact record, and receiving log. These documents should reinforce one another.

For HMG, the documentation review should also compare naming conventions. HMG, human menopausal gonadotropin, human menopausal gonadotrophin, menotropin, menotropins, and menotrophin may appear in different sources.

What Should the Final HMG Documentation Review Confirm?

Before completing procurement, confirm the following:

• The listing clearly identifies the research material and its use limitations.
• Scientific statements and documentation guidance identify their supporting sources.
• The lot-specific COA, analytical records, and RUO labeling are available and consistent.

Pure Lab Peptides supplies compounds for laboratory research use only. Products are not intended for human or animal consumption, diagnostic use, therapeutic use, clinical use, veterinary use, or as food, drugs, cosmetics, dietary supplements, or household products. Researchers are responsible for ensuring lawful, appropriate handling and use in accordance with applicable regulations and institutional guidelines.

Common Misunderstandings in HMG Research Procurement

Published literature does not equal product-use guidance. A paper can explain gonadotropin signaling, HMG composition, or analytical methods, but it cannot replace a batch-specific COA for a research material.

A purity percentage does not prove complete compound identity. HPLC may support purity review, while LC-MS or LC-MS/MS may support identity review depending on the method and sample context [19] [20].

A COA should be batch-specific. General product information is useful, but lot-level documentation is what connects the material to the record.

FSHR and LHCGR receptor literature provides background for gonadotropin research, not evidence of outcomes for this material [9] [11] .

Catalog specifications are not product-use guidance. Terms such as HMG 75 IU or 75iu belong in listing and identity context only.

Next Steps for RUO Documentation Review

Review the product-page documentation, COA details, analytical testing notes, and RUO labeling before evaluating HMG for laboratory research. For research teams comparing peptide suppliers, prioritize COA availability, transparent labeling, lot-level documentation, and clear separation between published literature and product positioning.

FAQs

What does research use only mean for HMG?

Research use only means HMG is intended solely for controlled laboratory research and documentation review. In this context, researchers evaluate product information, COA records, lot traceability, analytical testing, and supplier documentation.

What should researchers consider before they buy HMG for research?

Researchers should consider documentation first before they buy HMG for research. A research-focused review should include RUO labeling, compound identity, batch-specific COA records, lot number consistency, purity data, identity testing, and storage documentation. The strongest procurement review compares the product listing, supplier documentation, and laboratory records before any research material is accepted into inventory.

Are HMG and menotropin the same in research literature?

HMG and menotropin are closely related naming terms in research literature. HMG commonly refers to human menopausal gonadotropin, while menotropin or menotropins may describe gonadotropin preparations associated with FSH and LH activity [1]. Researchers should compare names, synonyms, CAS or database records, and COA documentation rather than relying on one label alone.

Why does a COA matter for HMG research materials?

A COA matters for HMG research materials because it provides batch-specific documentation for technical review. Researchers use it to check the compound name, lot number, COA date, purity method, identity method, and supplier record alignment. A COA should support research documentation, but it should also be compared with the label and product information.

How should published literature about HMG be interpreted?

Published literature about HMG should be interpreted as research context, not product positioning. Literature may describe gonadotropin preparations, biological activity, analytical characterization, or model-specific findings. Those findings should stay separate from RUO product claims, and researchers should rely on batch-specific documentation for the material being evaluated.

What documentation helps support HMG identity review?

Documentation that supports HMG identity review includes the product listing, synonym records, CAS or database references, COA documentation, lot number, analytical testing notes, and supplier documentation. For materials described as extracted from urine or aligned with gonadotropin preparations, identity review should be especially careful. HPLC and LC-MS records can support purity and identity review when properly documented [19] [20].

---

Researchers Cited in This Guide

The researchers listed below are cited for relevant published work. Their inclusion does not imply that they wrote, reviewed, or endorsed this guide or Pure Lab Peptides products.

Livio Casarini

Author profile: LE STUDIUM Profile

Livio Casarini’s publications address gonadotropin signaling, receptor pathways, and model-specific analysis of human menopausal gonadotrophin preparations. They provide scientific context on FSH, LH, hCG, composition, immunoassays, and early signaling measurements. Evaluate those findings separately from the COA and analytical records for the supplied lot.

Selected publications:

• Recent advances in understanding gonadotropin signaling — Faculty Reviews, 2021. DOI: 10.12703/r/10-41. PMID: [34046645].
• A peer-reviewed in vitro study of HMG preparation signaling and molecular composition — Molecular Human Reproduction, 2020. DOI: 10.1093/molehr/gaaa070. PMID: [33084890].

George R. Bousfield

Author profile: Wichita State University Profile

George R. Bousfield’s publications examine glycoprotein hormone structure, FSH glycosylation, mass spectrometry, and macro- and microheterogeneity in pituitary and urinary FSH materials. They provide background for interpreting HMG composition, glycan characterization, and source differences. This research complements, but does not replace, lot-specific identity and analytical documentation.

Selected publications:

• Follicle-Stimulating Hormone Glycobiology — Endocrinology, 2019. DOI: 10.1210/en.2019-00001. PMID: [31127275].
• Macro- and Micro-heterogeneity in Pituitary and Urinary Follicle-Stimulating Hormone Glycosylation — Journal of Glycomics & Lipidomics, 2014. PMID: [25722940].

REFERENCES

1. National Center for Biotechnology Information. Menotropins compound record. PubChem. Accessed 2026.
2. National Library of Medicine. Menotropins MeSH record. NCBI MeSH. Accessed 2026.
3. U.S. Food and Drug Administration. Menotropins substance registration record. FDA Global Substance Registration System. Accessed 2026.
4. National Institute of Diabetes and Digestive and Kidney Diseases. Gonadotropins overview. LiverTox, NCBI Bookshelf. 2018.
5. Casarini L, Simoni M. Recent advances in understanding gonadotropin signaling. Faculty Reviews. 2021. DOI: 10.12703/r/10-41.
6. U.S. Food and Drug Administration. RUO and IUO labeling guidance. FDA Guidance for Industry and FDA Staff. 2013; content current as of 2018.
7. Bousfield GR, et al. Gonadotropin structure and secretion review. Molecular and Cellular Endocrinology. 2011.
8. National Library of Medicine. Official menotropins label description. DailyMed. Accessed 2026.
9. National Center for Biotechnology Information. FSHR gene record. NCBI Gene. Accessed 2026.
10. UniProt Consortium. Follicle-stimulating hormone receptor record. UniProtKB. Accessed 2026.
11. National Center for Biotechnology Information. LHCGR gene record. NCBI Gene. Accessed 2026.
12. UniProt Consortium. Luteinizing hormone/choriogonadotropin receptor record. UniProtKB. Accessed 2026.
13. Capolupo A, et al. Analytical study of gonadotropin profiles in highly purified HMG preparations. International journal of molecular sciences. 2024. PMID: 39273352.
14. Casarini L, et al. LH and chorionic gonadotropin receptor biology review. Endocrine Reviews. 2018. DOI: 10.1210/er.2018-00065.
15. Menon KMJ, Menon B. Structure, function, and regulation of gonadotropin receptors. Molecular and Cellular Endocrinology. 2012.
16. van de Weijer BHM, Mulders JWM, Bos ES, Verhaert PDEM, van den Hooven HW. Compositional analysis of urinary-derived HMG preparation. Reproductive BioMedicine Online. 2003. DOI: 10.1016/S1472-6483(10)62071-8. PMID: 14680547.
17. National Institute of Standards and Technology. Reference materials and certificates. NIST. Accessed 2026.
18. International Council for Harmonisation. Q2(R2) analytical procedure validation guideline. ICH. 2023.
19. Mant CT, Hodges RS. HPLC analysis and purification of peptides. Methods in Molecular Biology. 2007.
20. Udeshi ND, et al. LC-MS methods for peptide and protein analysis. Nature Protocols. 2008.
21. Mouchahoir T, Schiel JE. LC-MS peptide mapping workflow for protein characterization. Analytical and Bioanalytical Chemistry. 2018.
22. Hollebrands B, et al. LC-MS identification of homologous peptides. Analytical and Bioanalytical Chemistry. 2023.
23. McCarthy D, et al. Reference standards supporting synthetic peptide quality attributes. The AAPS Journal. 2023.
24. International Organization for Standardization. ISO/IEC 17025 testing and calibration laboratories. ISO. Accessed 2026.
25. National Institute of Standards and Technology. NIST quality system for measurement services. NIST. Accessed 2026.

---

Research Disclaimer

This material is supplied strictly for in vitro laboratory research and is not for human or veterinary use. Published studies describe specific experimental materials, models, and methods; they do not establish the safety, efficacy, or suitability of this catalog product for non-research use. Review the original publications and the lot-specific analytical documentation independently.